Their investment in PGLC and Thunder gold are starting to look like smart moves. Silver price needs to break out over $21 and this will will continue to move higher. This hit $2.50 a share, in the last run and I think we could breakout well above that with less shares outstanding after the reverse merger they did last year.
The EU banks in serious trouble, so who knows what the flight to metals will end up being. The bankers also having trouble keeping the lid on things in metals. Tried desperately to knock it down after the fraudulent payroll numbers. The biotech clowns who sold this, now regretting that.
Interesting how the clowns here run away from their previous comments. PGLC a investment of levon, getting close to the breakeven at $5.03. The other mining investment they have about 3M shares in, also performing well that one is up 75% in a short period. VBIV just diluting and we still waiting for them to actually post the CMV trial to the clinical.gov site. Well you clowns invested at the wrong time and sold the wrong asset in this deal. Glad you finally realizing that you are not very bright. But somehow, i figure you already knew that.
Knowing you need VAPR to hit $153 a share to breakeven and it now trades at .003, we know we are in a better place then you vmax. BMGP did the honorable thing, they didn't dilute billions of shares. We still have a chance and only need a small amount of good news, where you need a miracle.
Hard to make up for the $10 kick in the pants the biotech investors took. But I did try my best to warn them. But arlo and k-9uwa just couldn't wrap their hands around the market cap. They just thought you go from point A to point b with Frost. That you can defy the laws of economics and create wealth. Now if you are dk1949, you paid the price twice here.
Levon bought 1.954M shares of PGLC before the RS. They paid $9.85M for them. Today it' s worth $9M. They need PGLC to $5.04 to be BE in that deal. Still has some work, but PGLC was added to the Russell.
Shame some of the biotech clowns sold this one and kept the biotech. Think .30 is in the cards before Oct.
PGLC broke through $4.50. Since Levon owns 2M shares this adds $1M in value to their investment capital. If yoy were dumb enough to sell the mining side, don't worry, no one thought you were to bright to begin with. Paying $18.80 for shares was the first give away.
Always dreaming rory. That RS years ago took the wind out of this and the RO were wasted money. Averaging down on this dog cost you clowns. I just knew I would be vindicated and leave you idiots talking to yourselves. How much they lose this quarter and I expect they will do another RS and start all over. How much is mechen now down? BTW fred, oos, tel, civil and most of the id's here are the same clown.
Still talking to yourselves? I still get a laugh at how fast Oss took down his racial rant. How telcomist gave accounting advice to investors without a clue. If anyone had listen to him, they would be pulling their hair out, sitting on a loss that they cannot take. Hope rory gets his money back some day.
Great investing rory. You are the man always holding a bag of krap.
Claimed he owned 200K shares between the share price of .42 and .47. If I am incorrect he can easily show us the trades. Like his actual bill for a fake trip to Tahiti. Now what is arlo valuation after not listening to my advice.....200K /40= 5K shares x 3.72= $18,600 = the 100K shares of mining he claimed he sold at .10 and his value is $28,600. Now what did he begin with 200K x .42 average= $84K. So by him not cleaning out his ears and instead using the k9uwa id, this cost him $55,400.
The 515M shares I warned about cost him large. The biotech clowns lack the attention to details. Today arlo needs $11 move to breakeven. Pretty difficult to get that kind of move with a biotech without revenues. Frost saw the $20M low hanging fruit and sold his followers out. The insiders of Scavf received 515M shares, today still valued at $48M, the biotech clowns who paid double for their shares, now see a company go from $112M on paper to now $22M.
Maybe arlo was too busy inventing new id's to understand that adding 515M shares wasn't going to immediate value this company at $355M. The value he needed to support his buys in the $18's. Today arlo has to invent imaginary flight connections, failing to include the airport code. I sometimes forget that arlo is 70 years old, with the intellect of a 8 year.
3.16M deferred revenues
Svac had $10M cash at the end of the 1Q. They also have on the books deferred revenues of 3.16M, with 1.57M listed as short term and 1.63M listed as long term. They believe that the $10M in cash will last them 12 months?????
I think hidden in these reports is that they have a strong contract to manufacture compounds for 10 different ph1 trials by other companies. They also have a deal with OPK to manufacture something on a billing basis. They do not mention the Dnase enzymes stuff at all.
As investors we have to understand where the funding will come from. Can LVP get legs, can they manufacture drugs on scale and profit from it. What exact did Frost see here? Missing from the Web page now is anything about Svac second drug. The GVHD? Curious minds want to know where did that go off too?
They also put out a SEC filing that they will use their web page instead of PR's to announce things. They suggest you get the VBIV alerts, so you are updated as fast as possible. Is this a cost saving move?
With a stock that is already down 75% from the highs, I think we as investors need a little bone thrown our way. The insiders handed themselves 515M shares and 650M divided by 40.
I don't expect an intelligent discussion, since most of the biotech investors here, can't tie their own shoes. We found that out at $18.80 when they just had blinders on. What could have been a very intelligent discussion, turned into a cluster F, with K(UWA and arlo, cdavis, Dk1949. Shame these clowns were this stupid. But then again they just like to sniff the hinney of Frost, with no brains to back their heads out of the crack.
I sense a surprise is coming. Things always take more time then we wish with a biotech. The unsophisticated think just the opposite. Well let's let arlo place his thumbs. I don't mind reproducing this 20 times. It's not like we will get anything intelligent from that side anyways.
Chase another wind mill arlo.
Arlo let's see 10 thumbs down here also. Maybe you can get federal aid being this dumb.
Looks like I don't need a new game, you seem to rile old arlo, better then I can. 10 thumbs because you showed up. Please chime in more, getting arlo to change his id that many times......PRICELESS.
svacfakeid39s57 • 38 minutes ago
users liked this posts
users disliked this posts
They are suppose to have the CMV trial started in the next 6 weeks. Still nothing up on the Clinical trial site. The $25M they needed to raise was canceled, so I expect some news on funding. Could they just license the vac-b to GSK for a nice large check?
There is a new update presentation on VBI site. It includes both companies and their outline going forward. I figure they need about $100M to advance the CMV, GBM, Vac-b, RSV and maybe a year away from seeing the cold storage benefits. They also state they are close to a third collaboration on the thermo stability.
Can he remember which id posted where? The counts are not even arlo and this is not fun unless you even this out and change those id's. You can be the poster child for stupid.